Byotrol PLC Directorate and Senior Management Changes (9864Q)
02 Novembre 2021 - 8:00AM
UK Regulatory
TIDMBYOT
RNS Number : 9864Q
Byotrol PLC
02 November 2021
Byotrol plc ("Byotrol" or the "Company")
Directorate and Senior Management Changes
The Board of Byotrol announces changes to the Board of Directors
and senior management positions within the Company.
Nic Hellyer, our part-time CFO since May 2019, has stated his
intention to resign from the Company to pursue other interests.
Byotrol is now in advanced discussions to replace him with a
full-time CFO to be based in our Chester headquarters. Nic has
agreed to stay on to manage the transition until the end of
December.
Rick Hayman, head of Byotrol's Professional division and
Managing Director of Medimark Scientific Limited, which Byotrol
formally acquired in January 2020, has now left Byotrol, but
remains a supportive shareholder with a continued interest in the
Company's future. Rick has been replaced by Mark Kyte, formerly a
senior sales and marketing professional at Diversey and at Gojo
Industries, two of the leading companies worldwide in our core
areas of business.
We are also pleased to announce the hiring of James Milnes as a
senior business development professional. James was previously UK
MD of Zoono Holdings Ltd and in that role launched and led the team
responsible for building Zoono's long-lasting antimicrobial
business in the UK and Europe.
Finally, we have restructured our technical team in readiness
for the next stage of growth and have now promoted Dr Chris
Plummer, previously head of microbiology at Byotrol, to Head of
Technology.
David Traynor, Chief Executive of Byotrol, said:
We thank Nic and Rick for their contributions to Byotrol and we
wish them every success in the future.
The Byotrol board has been very pleased with Dr Chris Plummer's
excellent work to date in our technical team and his promotion to
Head of Technology is very well deserved. We are also delighted to
welcome Mark Kyte and James Milnes into the business and look
forward to their contribution to our growth. We are very pleased to
be attracting such seasoned professionals into Byotrol as we look
to build a significantly larger business.
Enquiries:
Enquiries:
Byotrol plc
David Traynor - Chief Executive Officer
Nic Hellyer - Chief Financial Officer 01925 742 000
finnCap
Geoff Nash/Kate Bannatyne - Corporate Finance 020 7220 0500
Richard Chambers - ECM
Flagstaff Strategic and Investor Communications
Tim Thompson/Andrea Seymour/Fergus Mellon 020 7129 1474
byotrol@flagstaffcomms.com
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection
prevention and control company, operating globally in the
Healthcare, Industrial, Food and Consumer sectors, providing low
toxicity products with a broad-based and targeted efficacy across
all microbial classes; bacteria, viruses (including coronavirus),
fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where they can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, please go to byotrol.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOADKDBDFBDDADK
(END) Dow Jones Newswires
November 02, 2021 03:00 ET (07:00 GMT)
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2023 a Lug 2024